What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage?

1 day ago 3

Soumya Eswaran

Fri, January 16, 2026 astatine 7:25 AM CST 4 min read

Laughing Water Capital, an concern absorption company, released its fourth-quarter 2025 capitalist letter. In the quarter, Laughing Water Capital returned ~6.8%, bringing the full-year returns to ~3.9% nett of fees and expenses. In comparison, the SP500TR and R2000 returned astir 2.7% and 2.2%, respectively, successful the quarter, and finished the twelvemonth up by 17.9% and 12.8%, respectively. A transcript of the missive tin beryllium downloaded here. The Fund outperformed the indexes past year, but it has lagged down them successful the existent year. However, what truly matters is the cumulative returns implicit the agelong run, arsenic volatility tends to creaseless retired implicit time. The Portfolio is well-positioned successful this regard, delivering beardown results connected a cumulative ground since inception and returned astir 400%, vs ~332% for the SP500TR and ~175% for our astir applicable benchmark, the R2000. In addition, you tin cheque the Strategy’s apical 5 holdings to cognize its champion picks successful 2025.

In its fourth-quarter 2025 capitalist letter, Laughing Water Capital highlighted stocks specified arsenic Lifecore Biomedical, Inc. (NASDAQ:LFCR). Lifecore Biomedical, Inc. (NASDAQ:LFCR) is an integrated declaration improvement and manufacturing organization. On January 15, 2026, Lifecore Biomedical, Inc. (NASDAQ:LFCR) banal closed astatine $8.10 per share. One-month instrumentality of Lifecore Biomedical, Inc. (NASDAQ:LFCR) was 0.75%, and its shares gained 25.00% of their worth implicit the past 52 weeks. Lifecore Biomedical, Inc. (NASDAQ:LFCR) has a marketplace capitalization of $303.477 million.

Laughing Water Capital stated the pursuing regarding Lifecore Biomedical, Inc. (NASDAQ:LFCR) successful its 4th fourth 2025 capitalist letter:

"Lifecore Biomedical, Inc. (NASDAQ:LFCR) – Lifecore, besides discussed above, appreciated ~10% connected the twelvemonth contempt fantastic execution toward the lone happening that matters: expanding capableness utilization. Importantly for us, it seems arsenic if the indispensable elements of net powerfulness betterment and a re standing are already successful place. On descent 11 of the company’s capitalist presentation, the institution lays retired a span for however they expect to capable their capableness successful the years to come. This descent was archetypal presented astatine the company’s Investor Day successful November of 2024, and has not yet been updated. In this bridge, the “New Business” portion for the Mid Term and Long-Term are astir $11M and $34M respectively. The $34M of Long-Term caller concern represents astir 11% of full capacity.